Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient

Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient


Forward Pharma A/S plummeted 30 percent Friday on news of Biogen Inc 's patent victory over the active ingredient in their competing multiple sclerosis treatments. Biogen popped 1.5 percent on the news.



from Biotech News